Advertisement

Topics

Diabetic Retinopathy Market to Reach $10.11 Billion by 2022: Grand View Research, Inc.

20:00 EDT 22 Jul 2015 | Marketwired

SAN FRANCISCO, CA -- (Marketwired) -- 07/23/15 -- Global Diabetic Retinopathy Market is expected to reach USD 10.11 billion by 2022, according to a new study by Grand View Research Inc. Diabetic retinopathy is considered as a serious sight threatening complication that results due to long term diabetes. The treatment line selection for diabetic retinopathy depends on the severity of the condition and may require intraocular injections, anti VEGF drugs, laser surgery or vitrectomy. Increasing incidences of diabetes, rising geriatric population base and the growing demand for early detection are some high impact rendering drivers of the diabetic retinopathy market.

Browse full research report with TOC on "Diabetic Retinopathy Market Analysis By Type (Proliferative DR, Non-Proliferative DR), By Management (Anti-VEGF Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market

Furthermore, improving healthcare infrastructure, rising demand for cost-effective and safe treatment and rising focus of market players on emerging nations such as India and China are also anticipated to propel market growth. Presence of supportive government initiatives such as the Queen Elizabeth Diamond Jubilee Trust, which is taking initiatives for increasing patient awareness levels in order to promote regular retinal screening and early laser surgery to prevent permanent visual impairment and Ophthalmic Society of South Africa which works towards the improvement of reimbursement policies are anticipated to fuel the growth of the diabetic retinopathy market over the forecast period.

Further key findings from the study suggest:

Browse more reports of this category by Grand View Research:
http://www.grandviewresearch.com/industry/medical-devices

For the purpose of this study, Grand View Research has segmented the Diabetic Retinopathy Market on the basis of type, management and region:

Browse related reports by Grand View Research:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - apavirginia.org, mediafound.org, iamamontreal2013.com

Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: Web: NEXT ARTICLE

More From BioPortfolio on "Diabetic Retinopathy Market to Reach $10.11 Billion by 2022: Grand View Research, Inc. "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...